A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
University Health Network, Toronto
MacroGenics
Columbia University
Tvardi Therapeutics, Incorporated
NantBioScience, Inc.
Xencor, Inc.
Pfizer
Pfizer
Celldex Therapeutics
Xencor, Inc.
Bristol-Myers Squibb
Quadriga Biosciences, Inc.
Xencor, Inc.
Pfizer
National Institutes of Health Clinical Center (CC)
Santa Maria Biotherapeutics
OrienGene Biotechnology Ltd.
University of Chicago
National Institutes of Health Clinical Center (CC)